News

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
Officials at the FDA say they want to speed up approvals for new drugs and devices using tech like the new "Elsa" AI system. More news is on other uses of AI in health care, Eli Lilly refusing to work ...
Hims & Hers leverages ZAVA's expertise to enter Europe's weight-loss market, boosting growth and profitability. Read what ...
Hims & Hers (NYSE: HIMS) stock, a prominent player in the booming telehealth sector, has undeniably captured significant investor attention recently. Perhaps you, like many others, have been caught up ...
Eli Lilly & Co. will only work with telehealth firms that agree to stop selling copycat versions of weight-loss drugs, ...
Explore more
Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...
“With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products ...
Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
Telehealth platform Hims & Hers is set to acquire UK startup Zava to strengthen its international presence. Meanwhile, ...
Online pharmacies like Hims & Hers Health could lose the ability to sell knockoff ... have options to cover weight loss drugs like Wegovy if it's used for cardiovascular conditions. That's not the ...